TrialMedical oncology (Northwood, London, England)2016

Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent.

Ashish Saxena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.